NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

AdaptHealth Corp. (AHCO) Stock Analysis

AdaptHealth Corp. (AHCO) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

AHCO

$6.49

+$0.07 (+1.09%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AHCO with… →

AHCO Key Statistics

As of Sep 4, 2026
Trading
Open
$6.32
Previous Close
$6.42
Day's Range
6.24–6.52
52-Week Range
5.21–13.43
Volume
2.61M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.39
Valuation
Market Cap
$865.83M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.26
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.72
Financials (FY)
Revenue (FY)
$3.24B−0.49%
Net Income (FY)
−$70.79M−178.29%
Profit marginThe share of revenue left as profit after all costs and taxes.
−6.79%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
133.41M
1-Year Return
−29.53%
Dividend and dates
Earnings Date
November 3, 2026
Avg Volume
2.52M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AHCO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−34.84%
2025+4.62%
2024+30.59%
2023−62.07%
2022−21.42%
2021−34.88%
2020+242.08%
2019+11.70%
2018 (partial year)+1.34%

As of September 4, 2026.

AHCO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$3.24B−$70.79M−2.2%
2024$3.26B$90.42M2.8%
2023$3.20B−$678.90M−21.2%
2022$2.97B$69.32M2.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.24B$609.20M$186.27M−$70.79M−2.2%
2024$3.26B$681.09M$276.81M$90.42M2.8%
2023$3.20B$624.07M$232.39M−$678.90M−21.2%
2022$2.97B$580.12M$190.41M$69.32M2.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AHCO Valuation vs Medical Devices Median

Median of 151 stocks
MetricAHCOMedical Devices medianvs median
P/S ratio0.262.980.1x the median
Profit margin−6.79%−1.69%5.1 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

AdaptHealth Corp. (AHCO) is capitalised at $865.83M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 10,900.

The 52-week range on file runs from $5.21 to $13.43. AHCO last closed at $6.49 on September 4, 2026. That is +$0.07 (+1.09%) against the previous close. The latest close sits 24.57% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.24B. Against the prior fiscal year total of $3.26B, that is a change of −0.49%. The same year closed with a net loss of $70.79M. The reported profit margin is −6.79%. That is 5.1 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −1.72.

Across the 4 fiscal years on file, revenue moves from $2.97B in 2022 to $3.24B in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.26. On price-to-sales that is 0.1 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −29.53%. Across 5 years the annualized return works out at −23.26%. Beta against the wider market is reported at 1.39. Annualized volatility over the trailing 8 years is 57.07%.

Growth & Income

No dividend is on file for AHCO.

Across the complete calendar years on file, 2020 returned +242.08% and 2023 returned −62.07%. Of the 7 complete calendar years on file, 4 finished higher. So far in 2026 the price is −34.84%.

Peer Comparison

AdaptHealth Corp. (AHCO) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
AdaptHealth Corp. AHCO $865.83M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. AdaptHealth Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About AdaptHealth Corp.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Visit website →